Zohra Yaqhubi is a corporate associate in the Boston office of Kirkland & Ellis LLP. Zohra’s practice focuses on mergers and acquisitions for public and private companies primarily in the pharmaceutical and biotechnology industries.
Experience
Representative Matters
Prior to joining Kirkland, Zohra was involved in the following representative matters:
Chimerix in its $935 million sale to Jazz Pharmaceuticals
Evergreen Theragnostics in its sale to Lantheus for up to $1 billion
Vertex Pharmaceuticals in its $4.9 billion acquisition of Alpine Immune Sciences
Ambrx Biopharma in its $2 billion acquisition by Johnson & Johnson
POINT Biopharma in its $1.4 billion acquisition by Eli Lilly
CTI Biopharma in its $1.7 billion acquisition by Swedish Orphan Biovitrum
Zohra maintains an active pro bono practice providing legal representation to low-income tenants facing eviction, victims of domestic abuse, asylum seekers and survivors of human trafficking.
More
Credentials
Admissions & Qualifications
2022Massachusetts
2023New York
Education
Northwestern Pritzker School of LawJ.D.2022
Articles Editor, Northwestern University Law Review
Northwestern University Kellogg School of ManagementM.B.A.2022
